MYCN and neuroblastoma: The disease is noteworthy for its broad spectrum of clinical behavior and can be classified into three risk groups (low, intermediate, and high risk) based on age, MYCN status, and histology, as defined by the International Neuroblastoma Staging System (INSS) [2,14].